Donald L. Hagan LLC’s Pfizer PFE Stock Holding History

Donald L. Hagan LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,902	Closed	-$340K	–	107
2021 Q3	$340K	Sell	7,902 -7,996	-50%	-$354K	0.2%	82
2021 Q2	$623K	Buy	15,898 +91	+0.6%	+$3.54K	0.37%	65
2021 Q1	$573K	Sell	15,807 -313	-2%	-$11.1K	0.38%	64
2020 Q4	$593K	Sell	16,120 -3,934	-20%	-$144K	0.43%	51
2020 Q3	$698K	Sell	20,054 -9,587	-32%	-$336K	0.55%	36
2020 Q2	$920K	Sell	29,641 -4,517	-13%	-$153K	0.8%	30
2020 Q1	$1.17M	Buy	+34,158	New	+$1.16M	1.05%	23
2017 Q2	–	Sell	-10,881	Closed	-$353K	–	77
2017 Q1	$353K	Hold	10,881	–	–	0.34%	54
2016 Q4	$335K	Sell	10,881 -348	-3%	-$10.6K	0.32%	55
2016 Q3	$361K	Sell	11,229 -371	-3%	-$12.4K	0.36%	46
2016 Q2	$388K	Buy	11,600 +102	+0.9%	+$3.25K	0.38%	58
2016 Q1	$323K	Buy	11,498 +374	+3%	+$10.7K	0.3%	57
2015 Q4	$341K	Hold	11,124	–	–	0.34%	52
2015 Q3	$332K	Buy	11,124 +348	+3%	+$11.2K	0.3%	54
2015 Q2	$343K	Sell	10,776 -53	-0.5%	-$1.73K	0.32%	53
2015 Q1	$357K	Buy	10,829 +1,271	+13%	+$40.4K	0.36%	56
2014 Q4	$282K	Buy	+9,558	New	+$274K	0.26%	65

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Donald L. Hagan LLC's PFE Position: Q4 2021 in Review

Donald L. Hagan LLC sold out of Pfizer (PFE) in Q4 2021, closing a stake of 7,902 shares — an estimated $340K sold.

Donald L. Hagan LLC first reported a position in PFE in Q4 2014 and held it in 17 quarters. The position peaked at $1.17M in Q1 2020. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Donald L. Hagan LLC reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
Donald L. Hagan LLC sold 7,902 Pfizer shares in Q4 2021, an estimated $340K.
Donald L. Hagan LLC first reported a position in Pfizer in Q4 2014 and held it in 17 quarters.
Donald L. Hagan LLC's Pfizer position peaked at $1.17M in Q1 2020.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Donald L. Hagan LLC's 13F filing for Q4 2021, filed 20 Jan 2022.